Discontinuation report APO-RANITIDINE TABLET 150MG
Report ID | 60723 |
Drug Identification Number | 00733059 |
Brand name | APO-RANITIDINE TABLET 150MG |
Common or Proper name | RANITIDINE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 bls |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-02-11 |
Remaining supply date | 2019-02-11 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-02-13 | French | Compare |
v3 | 2019-02-13 | English | Compare |
v2 | 2018-09-08 | French | Compare |
v1 | 2018-09-08 | English | Compare |
Showing 1 to 4 of 4